Episode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices
The Readout Loud
00:00
Introduction
This week's episode of the read outloud, a weekly take poncast from stat. We'll look at regenerans purchase of checkmate farmarsuticals and why it may not be the good s investor steet. The fta has a program to speed oup the approval of so called break through medical devices but it appears to be benefiting companies rather than patients. And just what biata investers have ben waiting for right?
Transcript
Play full episode
